In a pivotal stride to address the growing AFib epidemic, OMRON Healthcare today announced the U.S. Food and Drug ...
OMRON Healthcare has received de novo authorization from the U.S. Food and Drug Administration (FDA) to market new home blood pressure monitors featuring AI-powered atrial fibrillation ...
The FDA has granted a de novo clearance to a wearable device—with a form factor you’re familiar with—that can check patients ...
Eko Health announced today that the American Medical Association issued a Category III CPT code for its Sensora platform.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback